These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Mapping the Neuroanatomy of ABHD16A, ABHD12, and Lysophosphatidylserines Provides New Insights into the Pathophysiology of the Human Neurological Disorder PHARC. Singh S; Joshi A; Kamat SS Biochemistry; 2020 Jun; 59(24):2299-2311. PubMed ID: 32462874 [TBL] [Abstract][Full Text] [Related]
4. The Lysophosphatidylserines-An Emerging Class of Signalling Lysophospholipids. Shanbhag K; Mhetre A; Khandelwal N; Kamat SS J Membr Biol; 2020 Oct; 253(5):381-397. PubMed ID: 32767057 [TBL] [Abstract][Full Text] [Related]
5. The loss of enzymatic activity of the PHARC-associated lipase ABHD12 results in increased phagocytosis that causes neuroinflammation. Singh S; Kamat SS Eur J Neurosci; 2021 Nov; 54(10):7442-7457. PubMed ID: 34727579 [TBL] [Abstract][Full Text] [Related]
6. Biochemical characterization of the PHARC-associated serine hydrolase ABHD12 reveals its preference for very-long-chain lipids. Joshi A; Shaikh M; Singh S; Rajendran A; Mhetre A; Kamat SS J Biol Chem; 2018 Nov; 293(44):16953-16963. PubMed ID: 30237167 [TBL] [Abstract][Full Text] [Related]
10. Phosphatidylserine-specific phospholipase A1 stimulates histamine release from rat peritoneal mast cells through production of 2-acyl-1-lysophosphatidylserine. Hosono H; Aoki J; Nagai Y; Bandoh K; Ishida M; Taguchi R; Arai H; Inoue K J Biol Chem; 2001 Aug; 276(32):29664-70. PubMed ID: 11395520 [TBL] [Abstract][Full Text] [Related]
11. Discovery and Optimization of Selective and in Vivo Active Inhibitors of the Lysophosphatidylserine Lipase α/β-Hydrolase Domain-Containing 12 (ABHD12). Ogasawara D; Ichu TA; Jing H; Hulce JJ; Reed A; Ulanovskaya OA; Cravatt BF J Med Chem; 2019 Feb; 62(3):1643-1656. PubMed ID: 30720278 [TBL] [Abstract][Full Text] [Related]
12. ABHD12 controls brain lysophosphatidylserine pathways that are deregulated in a murine model of the neurodegenerative disease PHARC. Blankman JL; Long JZ; Trauger SA; Siuzdak G; Cravatt BF Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1500-5. PubMed ID: 23297193 [TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidylserine: A Signaling Lipid with Implications in Human Diseases. Chakraborty A; Kamat SS Chem Rev; 2024 May; 124(9):5470-5504. PubMed ID: 38607675 [TBL] [Abstract][Full Text] [Related]
14. NADPH oxidase-dependent generation of lysophosphatidylserine enhances clearance of activated and dying neutrophils via G2A. Frasch SC; Berry KZ; Fernandez-Boyanapalli R; Jin HS; Leslie C; Henson PM; Murphy RC; Bratton DL J Biol Chem; 2008 Nov; 283(48):33736-49. PubMed ID: 18824544 [TBL] [Abstract][Full Text] [Related]
15. Blockade of the Lysophosphatidylserine Lipase ABHD12 Potentiates Ferroptosis in Cancer Cells. Kathman SG; Boshart J; Jing H; Cravatt BF ACS Chem Biol; 2020 Apr; 15(4):871-877. PubMed ID: 32195565 [TBL] [Abstract][Full Text] [Related]
16. Regulation of protein kinase C by lysophospholipids. Potential role in signal transduction. Oishi K; Raynor RL; Charp PA; Kuo JF J Biol Chem; 1988 May; 263(14):6865-71. PubMed ID: 3360811 [TBL] [Abstract][Full Text] [Related]
19. Histamine release from fawn-hooded rat mast cells is not potentiated by phosphatidylserine. Magro AM Immunology; 1981 Sep; 44(1):1-10. PubMed ID: 6168567 [TBL] [Abstract][Full Text] [Related]
20. A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates toll-like receptor 2 and affects immune polarization. van der Kleij D; Latz E; Brouwers JF; Kruize YC; Schmitz M; Kurt-Jones EA; Espevik T; de Jong EC; Kapsenberg ML; Golenbock DT; Tielens AG; Yazdanbakhsh M J Biol Chem; 2002 Dec; 277(50):48122-9. PubMed ID: 12359728 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]